Two Sigma Advisers’s Protalix BioTherapeutics PLX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-33,015
| Closed | -$84.5K | – | 2486 |
|
|
2025
Q1 | $84.5K | Buy |
+33,015
| New | +$84.5K | ﹤0.01% | 2260 |
|
|
2023
Q2 | – | Sell |
-19,900
| Closed | -$41.8K | – | 2600 |
|
|
2023
Q1 | $41.8K | Sell |
19,900
-700
| -3% | -$1.47K | ﹤0.01% | 2467 |
|
|
2022
Q4 | $28.2K | Sell |
20,600
-4,700
| -19% | -$6.44K | ﹤0.01% | 2407 |
|
|
2022
Q3 | $26K | Sell |
25,300
-48,371
| -66% | -$49.7K | ﹤0.01% | 2429 |
|
|
2022
Q2 | $80K | Buy |
73,671
+14,771
| +25% | +$16K | ﹤0.01% | 2420 |
|
|
2022
Q1 | $62K | Sell |
58,900
-41,000
| -41% | -$43.2K | ﹤0.01% | 2563 |
|
|
2021
Q4 | $83K | Buy |
99,900
+85,700
| +604% | +$71.2K | ﹤0.01% | 2431 |
|
|
2021
Q3 | $19K | Buy |
+14,200
| New | +$19K | ﹤0.01% | 2404 |
|
|
2015
Q3 | – | Sell |
-1,030
| Closed | -$20K | – | 1938 |
|
|
2015
Q2 | $20K | Buy |
+1,030
| New | +$20K | ﹤0.01% | 1853 |
|
|
2013
Q4 | – | Sell |
-1,120
| Closed | -$50K | – | 1933 |
|
|
2013
Q3 | $50K | Sell |
1,120
-209
| -16% | -$9.33K | ﹤0.01% | 1544 |
|
|
2013
Q2 | $64K | Buy |
+1,329
| New | +$64K | ﹤0.01% | 1533 |
|